sr 140333 has been researched along with xe 991, anthracenone in 1 studies
Studies (sr 140333) | Trials (sr 140333) | Recent Studies (post-2010) (sr 140333) | Studies (xe 991, anthracenone) | Trials (xe 991, anthracenone) | Recent Studies (post-2010) (xe 991, anthracenone) |
---|---|---|---|---|---|
236 | 0 | 12 | 150 | 0 | 82 |
Protein | Taxonomy | sr 140333 (IC50) | xe 991, anthracenone (IC50) |
---|---|---|---|
Potassium voltage-gated channel subfamily KQT member 2 | Homo sapiens (human) | 0.055 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Endo, T; Komatsu, Y; Yanagawa, Y | 1 |
1 other study(ies) available for sr 140333 and xe 991, anthracenone
Article | Year |
---|---|
Substance P Activates Ca2+-Permeable Nonselective Cation Channels through a Phosphatidylcholine-Specific Phospholipase C Signaling Pathway in nNOS-Expressing GABAergic Neurons in Visual Cortex.
Topics: Animals; Anthracenes; Boron Compounds; Calcium; Calcium Channel Blockers; Dose-Response Relationship, Drug; Electric Stimulation; Excitatory Amino Acid Agents; GABAergic Neurons; Glutamate Decarboxylase; Imidazoles; In Vitro Techniques; Isoindoles; Mice; Mice, Transgenic; Neurokinin-1 Receptor Antagonists; Nitric Oxide Synthase Type III; Patch-Clamp Techniques; Piperidines; Quinolines; Quinuclidines; Signal Transduction; Substance P; Type C Phospholipases; Visual Cortex | 2016 |